Yourgene Health Plc (AIM:YGEN) agreed to acquire Coastal Genomics, Inc. for $13.5 million on August 4, 2020. The consideration will be paid as cash consideration of $3 million, $2.5 million in equity of Yourgene Health, contingent cash consideration of $2 million should Coastal Genomics generate revenues of at least $4 million for the year ended March 31, 2022 and contingent cash consideration of $4 million should Coastal Genomics generate revenues of at $8.5 million in FY 2023, two further elements of consideration of $1 million each for early strategic customer wins, payable in Yourgene Health Canada Investments Ltd shares and ordinary shares of subject to lock-up periods of 12 months. All share based consideration will be subject to an initial lock-up period (in the case of the shares issued on Completion, for three years from Completion and, in the case of shares issues in respect of strategic customer wins, for 12 months after issuance) and subsequent orderly market arrangements. The cash consideration will be funded from proposed placing on August 4, 2020. Coastal Genomics reported revenues $0.6 million in unaudited revenues, EBITDA loss of $0.6 million and net assets of $8 million for the year ended December 31, 2019. Key members of the Management team and staff of Coastal Genomics will be incentivised to remain with the business via the contingent consideration. The transaction is conditional on the admission of the Placing Shares to trading on AIM, a market operated by the LSE ("AIM") becoming effective ("Admission"), and also on procedural completion steps. Completion of the acquisition is expected to occur on Admission of placing shares. Liam Murray, James Caithie and Ludovico Lazzaretti of Cairn Financial Advisers LLP acted as financial advisors for Yourgene Health. Roger Har and Justine Delroy of Addleshaw Goddard acted as legal advisors to Yourgene Health. Yourgene Health Plc (AIM:YGEN) completed the acquisition of Coastal Genomics, Inc. on August 5, 2020. As of March 1, 2021, the first earn-out milestone from the acquisition was triggered and on April 12, 2021, Yourgene Health Plc issued 4.7 million new shares to the former shareholders of Coastal. As of June 21, 2021, the second earn-out milestone was triggered and on August 11, 2021, Yourgene Health Plc issued 4.9 million new shares to the former shareholders of Coastal.